Skip to search formSkip to main contentSkip to account menu

imoproxifan

Known as: 4-(3-(1H-imidazol-4-yl)propyloxy)phenylethanone oxime 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Histamine AntagonistsImidazolesOximes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Модифицирующее влияние антагониста Н3/Н4-гистаминовых рецепторов имопроксифана на продукцию интерлейкина-10 в мононуклеарных клеточных культурах у больных инфарктом миокарда
The problem of histamine and cytokine activation in patients with Q-positive myocardial infarction (Q-MI) and opportunities of… 
2008
2008
Effects of the H3/H4 Receptor Antagonist Imoproxifan (IMP) on IgE-regulatory Cytokine Production
2005
2005
Non-imidazole histamine NO-donor H3-antagonists.
2005
2005
Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives.
2000
2000
New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
Histamine H(3)-receptor antagonists of the proxifan series are described. The novel compounds possess a 4-(3-(phenoxy)propyl)-1H… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)